Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.

Author: DengChao, HanMei, HuangXu-Feng

Paper Details 
Original Abstract of the Article :
Aripiprazole has been used effectively to treat schizophrenia in the clinic; however, its mechanisms of action are not clear. This study examined how short- and long-term aripiprazole treatment affects dopaminergic transmission in mesolimbic and nigrostriatal pathways. For comparison, the effects of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1017/S1461145709009948

データ提供:米国国立医学図書館(NLM)

Aripiprazole: A Selective Approach to Dopamine Regulation in Schizophrenia

Schizophrenia is a complex and debilitating mental illness. This study explores the mechanisms of action of aripiprazole, an antipsychotic medication, on dopaminergic transmission in the brain. The researchers examined the effects of aripiprazole on different dopaminergic pathways, comparing its effects to those of other antipsychotics, haloperidol and olanzapine.

Aripiprazole: Targeting Dopamine Transmission with Precision

The study suggests that aripiprazole exhibits a selective effect on the mesolimbic dopaminergic pathway, a brain region associated with reward and motivation. The researchers observed significant changes in dopamine synthesis and receptor expression in the mesolimbic pathway, but not in the nigrostriatal pathway, which is involved in motor control. This selective targeting might explain aripiprazole's efficacy in controlling schizophrenia symptoms while minimizing extrapyramidal side effects, a common issue with other antipsychotics. It's like navigating a desert with a precise map, carefully targeting specific areas to reach the desired destination while avoiding treacherous routes.

New Insights into Antipsychotic Treatment

This study provides valuable insights into the neurobiological mechanisms underlying the action of aripiprazole. The findings suggest that aripiprazole's selective effects on the mesolimbic pathway might contribute to its therapeutic efficacy and favorable side-effect profile. It's like discovering a new and more efficient route through the desert, offering a smoother and safer journey for those seeking relief from schizophrenia symptoms.

Dr.Camel's Conclusion

This study sheds light on the selective effects of aripiprazole, an antipsychotic medication, on dopamine transmission in the brain. The research findings, like a carefully crafted map of the desert, highlight the importance of precise targeting in treating complex conditions like schizophrenia.

Date :
  1. Date Completed 2011-09-06
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

19203411

DOI: Digital Object Identifier

10.1017/S1461145709009948

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.